ESC 365 - Central sleep apnea in patients with chronic heart failure and its treatment with acetazolamide

HFA Premium Access

Central sleep apnea in patients with chronic heart failure and its treatment with acetazolamide

Session: Poster Session 3 - Chronic Heart Failure – Treatment

Topic: Pharmacotherapy

Speaker: Doctor K. Sorokina (Moscow, RU)

Event: Heart Failure 2019

Congress Presentation

Add to my library

About the speaker

Doctor Kliya Sorokina

I.M. Sechenov First Moscow State Medical University, Moscow (Russian Federation)

0 follower

56 more presentations in this session

Effects of mineralocorticoid ceceptor antagonists (MRA) in heart failure patients after up to 12 months of follow-up.

Speaker: Doctor L. Buttigieg (Msida, MT)

Sacubitril valsartan, a multicentric experience

Speaker: Mr F. Cortes (Sevilla, ES)

Reduction of NT-proBNP in patients with type 2 diabetes mellitus and heart failure with preserved ejection fraction in short-term treatment with empagliflozin on top of existing therapy

Speaker: Professor B. Kanazirev (Varna, BG)

Effects of sacubitril/valsartan on real-world patients with heart failure due to non-ischemic cardiomyopathy

Speaker: Associate Professor C. Hsu (Taipei, TW)

Effects of ivabradine on patients with depressed left ventricular ejection fraction after cardiac resynchronization therapy

Speaker: Doctor C. Hsieh (Taipei, TW)

Access the full session

Poster Session 3 - Chronic Heart Failure – Treatment

Speakers: Doctor K. Sorokina, Doctor L. Buttigieg, Mr F. Cortes, Professor B. Kanazirev, Associate Professor C. Hsu...

About the event

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources